Reed Smith has taken a lead role on a licence and supply agreement for an Ebola vaccine developed by Danish company Bavarian Nordic.

London-based life sciences partner John Wilkinson advised Bavarian Nordic on the deal, alongside partners Michael Pitzner-Bruun and Marianne Philip at Copenhagen-headquartered firm Kromann Reumert.